Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Amoxicillin Challenge in Primary Care
NCT05165212Phase 4Withdrawn
- Sponsor
- University at Buffalo
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of amoxicillin in penicillin allergy, sponsored by University at Buffalo. Planned start Dec 2024; status: withdrawn.
02
Drugs
amoxicillin
03
Conditions
penicillin allergy
Beyond the preview
Go deeper on NCT05165212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05165212.